Position in PFE
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$905,793
+$72,660 QoQ
Shares Held
37,616
+26.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#1,387
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NTV Asset Management LLC holds $67,135,913 across 11 Drug Manufacturers - General names. PFE ranks #8 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,611 | $36,715,754 | |
| 2 | ABBV |
AbbVie Inc.
|
35,144 | $8,843,636 | |
| 3 | JNJ |
Johnson & Johnson
|
32,909 | $8,357,898 | |
| 4 | AMGN |
Amgen Inc
|
10,347 | $3,746,855 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,525 | $2,765,962 | |
| 6 | AZN |
Astrazeneca PLC
|
13,967 | $2,648,422 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,439 | $1,465,795 | |
| 8 | PFE |
Pfizer Inc
This page
|
37,616 | $905,793 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $905,793 | 37,616 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $833,133 | 29,670 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $858,103 | 34,462 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,097,500 | 43,073 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,129,365 | 46,591 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $1,450,334 | 57,235 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,539,323 | 58,022 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $1,922,455 | 66,429 | Shares | Sole | 2024-10-31 | |
| 2024-06-30 | $1,816,573 | 64,924 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,853,006 | 66,775 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $1,871,177 | 64,994 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $2,272,941 | 68,524 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,702,435 | 73,676 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $3,131,196 | 76,745 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $3,988,777 | 77,845 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $3,428,377 | 78,345 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $4,110,774 | 78,405 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $4,074,557 | 78,705 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $4,679,417 | 79,245 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $3,518,433 | 81,805 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $3,111,927 | 79,467 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,971,258 | 82,011 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $3,196,101 | 86,827 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $3,108,853 | 84,710 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $2,721,787 | 83,235 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,707,484 | 82,950 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||